Business Description

Description
Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG.
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -11.81
12-1 Month Momentum % -3.04

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
FCF Margin % 61.36

GF Value Rank

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2024-05-09 Est.)

STU:PCBK's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Sesen Bio Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 40.4
EPS (TTM) (€) -1.835
Beta 0
Volatility % 95.67
14-Day RSI 0
14-Day ATR (€) 0.325571
20-Day SMA (€) 0
12-1 Month Momentum % -3.04
52-Week Range (€) 6.972 - 18.336
Shares Outstanding (Mil) 10.17

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Sesen Bio Inc Filings

Filing Date Document Date Form
No Filing Data

Sesen Bio Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

Sesen Bio Inc Frequently Asked Questions

What is Sesen Bio Inc(STU:PCBK)'s stock price today?
The current price of STU:PCBK is €10.60. The 52 week high of STU:PCBK is €18.34 and 52 week low is €6.97.
When is next earnings date of Sesen Bio Inc(STU:PCBK)?
The next earnings date of Sesen Bio Inc(STU:PCBK) is 2024-05-09 Est..
Does Sesen Bio Inc(STU:PCBK) pay dividends? If so, how much?
Sesen Bio Inc(STU:PCBK) does not pay dividend.

Press Release

Subject Date
No Press Release